ID   FIP1_RAT                Reviewed;         536 AA.
AC   Q5U317;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 1.
DT   24-JUL-2024, entry version 113.
DE   RecName: Full=Pre-mRNA 3'-end-processing factor FIP1;
DE   AltName: Full=FIP1-like 1 protein;
GN   Name=Fip1l1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-88; SER-434; THR-436; SER-442
RP   AND SER-496, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Component of the cleavage and polyadenylation specificity
CC       factor (CPSF) complex that plays a key role in pre-mRNA 3'-end
CC       formation, recognizing the AAUAAA signal sequence and interacting with
CC       poly(A) polymerase and other factors to bring about cleavage and
CC       poly(A) addition. FIP1L1 contributes to poly(A) site recognition and
CC       stimulates poly(A) addition. Binds to U-rich RNA sequence elements
CC       surrounding the poly(A) site. May act to tether poly(A) polymerase to
CC       the CPSF complex (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Component of the cleavage and polyadenylation specificity
CC       factor (CPSF) complex, composed of CPSF1, CPSF2, CPSF3, CPSF4 and
CC       FIP1L1. Found in a complex with CPSF1, FIP1L1 and PAPOLA. Interacts
CC       with CPSF1, CPSF4, CSTF2 and CSTF3. Interacts with AHCYL1 (when
CC       phosphorylated); the interaction is direct and associates AHCYL1 with
CC       the CPSF complex and RNA. Interacts with PAPOLA; the interaction seems
CC       to be increased by the interaction with AHCYL1. Interacts with
CC       NUDT21/CPSF5; this interaction occurs in a RNA sequence-specific
CC       manner. Interacts (preferentially via unphosphorylated form and
CC       Arg/Glu/Asp-rich domain) with CPSF6 (via Arg/Ser-rich domain); this
CC       interaction mediates, at least in part, the interaction between the
CC       CFIm and CPSF complexes and may be inhibited by CPSF6 hyper-
CC       phosphorylation. Interacts (preferentially via unphosphorylated form
CC       and Arg/Asp/Glu-rich domain) with CPSF7 (via Arg/Ser-rich domain); this
CC       interaction mediates, at least in part, the interaction between the
CC       CFIm and CPSF complexes and may be inhibited by CPSF7 hyper-
CC       phosphorylation. {ECO:0000250|UniProtKB:Q6UN15,
CC       ECO:0000250|UniProtKB:Q9D824}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the FIP1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC085767; AAH85767.1; -; mRNA.
DR   RefSeq; NP_001008296.1; NM_001008295.1.
DR   AlphaFoldDB; Q5U317; -.
DR   SMR; Q5U317; -.
DR   IntAct; Q5U317; 2.
DR   STRING; 10116.ENSRNOP00000072529; -.
DR   iPTMnet; Q5U317; -.
DR   PhosphoSitePlus; Q5U317; -.
DR   jPOST; Q5U317; -.
DR   PaxDb; 10116-ENSRNOP00000049728; -.
DR   GeneID; 289582; -.
DR   KEGG; rno:289582; -.
DR   UCSC; RGD:1309336; rat.
DR   AGR; RGD:1309336; -.
DR   CTD; 81608; -.
DR   RGD; 1309336; Fip1l1.
DR   VEuPathDB; HostDB:ENSRNOG00000002275; -.
DR   eggNOG; KOG1049; Eukaryota.
DR   HOGENOM; CLU_035577_1_0_1; -.
DR   InParanoid; Q5U317; -.
DR   OrthoDB; 449619at2759; -.
DR   Reactome; R-RNO-159231; Transport of Mature mRNA Derived from an Intronless Transcript.
DR   Reactome; R-RNO-72187; mRNA 3'-end processing.
DR   Reactome; R-RNO-72203; Processing of Capped Intron-Containing Pre-mRNA.
DR   Reactome; R-RNO-73856; RNA Polymerase II Transcription Termination.
DR   Reactome; R-RNO-77595; Processing of Intronless Pre-mRNAs.
DR   PRO; PR:Q5U317; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   Bgee; ENSRNOG00000002275; Expressed in ovary and 20 other cell types or tissues.
DR   ExpressionAtlas; Q5U317; baseline and differential.
DR   GO; GO:0005847; C:mRNA cleavage and polyadenylation specificity factor complex; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   InterPro; IPR007854; Fip1_dom.
DR   InterPro; IPR051187; Pre-mRNA_3'-end_processing_reg.
DR   PANTHER; PTHR13484; FIP1-LIKE 1 PROTEIN; 1.
DR   PANTHER; PTHR13484:SF9; PRE-MRNA 3'-END-PROCESSING FACTOR FIP1; 1.
DR   Pfam; PF05182; Fip1; 1.
PE   1: Evidence at protein level;
KW   mRNA processing; Nucleus; Phosphoprotein; Reference proteome; RNA-binding.
FT   CHAIN           1..536
FT                   /note="Pre-mRNA 3'-end-processing factor FIP1"
FT                   /id="PRO_0000215040"
FT   REGION          1..296
FT                   /note="Necessary for stimulating PAPOLA activity"
FT                   /evidence="ECO:0000250"
FT   REGION          1..110
FT                   /note="Sufficient for interaction with PAPOLA"
FT                   /evidence="ECO:0000250"
FT   REGION          1..95
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          136..219
FT                   /note="Sufficient for interaction with CPSF4"
FT                   /evidence="ECO:0000250"
FT   REGION          212..246
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          300..536
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          383..536
FT                   /note="Sufficient for interaction with CPSF1 and CSTF3"
FT                   /evidence="ECO:0000250"
FT   REGION          397..432
FT                   /note="Arg/Asp/Glu-rich domain"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UN15"
FT   COMPBIAS        300..344
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        373..387
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        391..503
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         84
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D824"
FT   MOD_RES         86
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D824"
FT   MOD_RES         88
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         366
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UN15"
FT   MOD_RES         434
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         436
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         438
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UN15"
FT   MOD_RES         442
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         496
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   536 AA;  60188 MW;  B608BE48974164C0 CRC64;
     MSAGEVERLV ELSGGTGGDE EEEWLYGGPW DVHVHSDLAK DLDENEVERP EEENASANPP
     SGIEEEAAEN GVAKPKVTET EDDSDSDSDD DEDDVHVTIG DIKTGAPQYG SYGTAPVNLN
     IKAGGRVYGN TGTKVKGVDL DAPGSINGVP LLEVDLDSFE DKPWRKPGAD LSDYFNYGFN
     EDTWKAYCEK QKRIRMGLEV IPVTSTTNKI TVQQGRTGNS EKEAALPSTK AEFTSPPSLF
     KTGLPPSRRL PGAIDVIGQT ITISRVEGRR RANENSNIQV LSDRSATEVD NNFSKPPPFF
     PPGAPPTHLP PPPFLPPPPT VSTAPPLIPP PGFPPPPGAP PPSLIPTIES GHSSGYDSRS
     ARAFPYGNVA FPHLTSSAPS WPSLVDTTKQ WDYYARREKD RDRDRERDRD RERERDRDRE
     RERTRERERE RDHSPTPSVF NSDEERYRYR EYAERGYERH RASREKEERH RERRHREKEE
     TRHKSSRSNS RRRHESEEGD SHRRHKHKKS KRSKEGKEAG SEPVPEQEST EAAPAE
//
